LinkedIn Profile

Access Cidara Therapeutics historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Sector Industry
nasdaq:cdtx 5258636 Aug 18th, 2021 12:00AM Cidara Therapeutics 3.0K 95.00 Open Biotechnology Aug 18th, 2021 08:32AM Aug 18th, 2021 08:32AM Cidara (NASDAQ: CDTX) is developing therapeutics to improve the standard of care for patients facing serious fungal or viral infections. The Company’s portfolio is comprised of breakthrough approaches aimed at transforming existing treatment and prevention paradigms, first with its lead Phase 3 antifungal candidate, rezafungin, in addition to antiviral conjugates (AVCs) targeting influenza and other viral diseases from Cidara’s proprietary Cloudbreak antiviral platform. Cidara is headquartered in San Diego, California. Open Open 6310 Nancy Ridge Drive, Suite 101 San Diego CA US 92121 Health Care Pharmaceuticals & Biotechnology
nasdaq:cdtx 5258636 Aug 17th, 2021 12:00AM Cidara Therapeutics 3.0K 95.00 Open Biotechnology Aug 17th, 2021 08:28AM Aug 17th, 2021 08:28AM Cidara (NASDAQ: CDTX) is developing therapeutics to improve the standard of care for patients facing serious fungal or viral infections. The Company’s portfolio is comprised of breakthrough approaches aimed at transforming existing treatment and prevention paradigms, first with its lead Phase 3 antifungal candidate, rezafungin, in addition to antiviral conjugates (AVCs) targeting influenza and other viral diseases from Cidara’s proprietary Cloudbreak antiviral platform. Cidara is headquartered in San Diego, California. Open Open 6310 Nancy Ridge Drive, Suite 101 San Diego CA US 92121 Health Care Pharmaceuticals & Biotechnology
nasdaq:cdtx 5258636 Aug 16th, 2021 12:00AM Cidara Therapeutics 3.0K 95.00 Open Biotechnology Aug 16th, 2021 08:13AM Aug 16th, 2021 08:13AM Cidara (NASDAQ: CDTX) is developing therapeutics to improve the standard of care for patients facing serious fungal or viral infections. The Company’s portfolio is comprised of breakthrough approaches aimed at transforming existing treatment and prevention paradigms, first with its lead Phase 3 antifungal candidate, rezafungin, in addition to antiviral conjugates (AVCs) targeting influenza and other viral diseases from Cidara’s proprietary Cloudbreak antiviral platform. Cidara is headquartered in San Diego, California. Open Open 6310 Nancy Ridge Drive, Suite 101 San Diego CA US 92121 Health Care Pharmaceuticals & Biotechnology
nasdaq:cdtx 5258636 Aug 15th, 2021 12:00AM Cidara Therapeutics 3.0K 95.00 Open Biotechnology Aug 15th, 2021 03:38PM Aug 15th, 2021 03:38PM Cidara (NASDAQ: CDTX) is developing therapeutics to improve the standard of care for patients facing serious fungal or viral infections. The Company’s portfolio is comprised of breakthrough approaches aimed at transforming existing treatment and prevention paradigms, first with its lead Phase 3 antifungal candidate, rezafungin, in addition to antiviral conjugates (AVCs) targeting influenza and other viral diseases from Cidara’s proprietary Cloudbreak antiviral platform. Cidara is headquartered in San Diego, California. Open Open 6310 Nancy Ridge Drive, Suite 101 San Diego CA US 92121 Health Care Pharmaceuticals & Biotechnology
nasdaq:cdtx 5258636 Aug 14th, 2021 12:00AM Cidara Therapeutics 3.0K 95.00 Open Biotechnology Aug 14th, 2021 11:33AM Aug 14th, 2021 11:33AM Cidara (NASDAQ: CDTX) is developing therapeutics to improve the standard of care for patients facing serious fungal or viral infections. The Company’s portfolio is comprised of breakthrough approaches aimed at transforming existing treatment and prevention paradigms, first with its lead Phase 3 antifungal candidate, rezafungin, in addition to antiviral conjugates (AVCs) targeting influenza and other viral diseases from Cidara’s proprietary Cloudbreak antiviral platform. Cidara is headquartered in San Diego, California. Open Open 6310 Nancy Ridge Drive, Suite 101 San Diego CA US 92121 Health Care Pharmaceuticals & Biotechnology
nasdaq:cdtx 5258636 Aug 13th, 2021 12:00AM Cidara Therapeutics 3.0K 95.00 Open Biotechnology Aug 13th, 2021 10:04AM Aug 13th, 2021 10:04AM Cidara (NASDAQ: CDTX) is developing therapeutics to improve the standard of care for patients facing serious fungal or viral infections. The Company’s portfolio is comprised of breakthrough approaches aimed at transforming existing treatment and prevention paradigms, first with its lead Phase 3 antifungal candidate, rezafungin, in addition to antiviral conjugates (AVCs) targeting influenza and other viral diseases from Cidara’s proprietary Cloudbreak antiviral platform. Cidara is headquartered in San Diego, California. Open Open 6310 Nancy Ridge Drive, Suite 101 San Diego CA US 92121 Health Care Pharmaceuticals & Biotechnology
nasdaq:cdtx 5258636 Aug 12th, 2021 12:00AM Cidara Therapeutics 3.0K 95.00 Open Biotechnology Aug 12th, 2021 08:53AM Aug 12th, 2021 08:53AM Cidara (NASDAQ: CDTX) is developing therapeutics to improve the standard of care for patients facing serious fungal or viral infections. The Company’s portfolio is comprised of breakthrough approaches aimed at transforming existing treatment and prevention paradigms, first with its lead Phase 3 antifungal candidate, rezafungin, in addition to antiviral conjugates (AVCs) targeting influenza and other viral diseases from Cidara’s proprietary Cloudbreak antiviral platform. Cidara is headquartered in San Diego, California. Open Open 6310 Nancy Ridge Drive, Suite 101 San Diego CA US 92121 Health Care Pharmaceuticals & Biotechnology
nasdaq:cdtx 5258636 Aug 11th, 2021 12:00AM Cidara Therapeutics 3.0K 96.00 Open Biotechnology Aug 10th, 2021 10:28PM Aug 10th, 2021 10:28PM Cidara (NASDAQ: CDTX) is developing therapeutics to improve the standard of care for patients facing serious fungal or viral infections. The Company’s portfolio is comprised of breakthrough approaches aimed at transforming existing treatment and prevention paradigms, first with its lead Phase 3 antifungal candidate, rezafungin, in addition to antiviral conjugates (AVCs) targeting influenza and other viral diseases from Cidara’s proprietary Cloudbreak antiviral platform. Cidara is headquartered in San Diego, California. Open Open 6310 Nancy Ridge Drive, Suite 101 San Diego CA US 92121 Health Care Pharmaceuticals & Biotechnology
nasdaq:cdtx 5258636 Aug 10th, 2021 12:00AM Cidara Therapeutics 3.0K 96.00 Open Biotechnology Aug 10th, 2021 09:59AM Aug 10th, 2021 09:59AM Cidara (NASDAQ: CDTX) is developing therapeutics to improve the standard of care for patients facing serious fungal or viral infections. The Company’s portfolio is comprised of breakthrough approaches aimed at transforming existing treatment and prevention paradigms, first with its lead Phase 3 antifungal candidate, rezafungin, in addition to antiviral conjugates (AVCs) targeting influenza and other viral diseases from Cidara’s proprietary Cloudbreak antiviral platform. Cidara is headquartered in San Diego, California. Open Open 6310 Nancy Ridge Drive, Suite 101 San Diego CA US 92121 Health Care Pharmaceuticals & Biotechnology
nasdaq:cdtx 5258636 Aug 9th, 2021 12:00AM Cidara Therapeutics 3.0K 96.00 Open Biotechnology Aug 9th, 2021 08:34AM Aug 9th, 2021 08:34AM Cidara (NASDAQ: CDTX) is developing therapeutics to improve the standard of care for patients facing serious fungal or viral infections. The Company’s portfolio is comprised of breakthrough approaches aimed at transforming existing treatment and prevention paradigms, first with its lead Phase 3 antifungal candidate, rezafungin, in addition to antiviral conjugates (AVCs) targeting influenza and other viral diseases from Cidara’s proprietary Cloudbreak antiviral platform. Cidara is headquartered in San Diego, California. Open Open 6310 Nancy Ridge Drive, Suite 101 San Diego CA US 92121 Health Care Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.